Novo Nordisk Balance Sheet Health
Financial Health criteria checks 4/6
Novo Nordisk has a total shareholder equity of DKK93.0B and total debt of DKK26.5B, which brings its debt-to-equity ratio to 28.5%. Its total assets and total liabilities are DKK300.1B and DKK207.1B respectively. Novo Nordisk's EBIT is DKK93.7B making its interest coverage ratio 674.1. It has cash and short-term investments of DKK47.6B.
Key information
28.5%
Debt to equity ratio
DKK 26.54b
Debt
| Interest coverage ratio | 674.1x |
| Cash | DKK 47.60b |
| Equity | DKK 92.99b |
| Total liabilities | DKK 207.11b |
| Total assets | DKK 300.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NOVOB's short term assets (DKK142.2B) do not cover its short term liabilities (DKK172.6B).
Long Term Liabilities: NOVOB's short term assets (DKK142.2B) exceed its long term liabilities (DKK34.6B).
Debt to Equity History and Analysis
Debt Level: NOVOB has more cash than its total debt.
Reducing Debt: NOVOB's debt to equity ratio has increased from 0.7% to 28.5% over the past 5 years.
Debt Coverage: NOVOB's debt is well covered by operating cash flow (401.2%).
Interest Coverage: NOVOB's interest payments on its debt are well covered by EBIT (674.1x coverage).